SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/205823"
 

Search: onr:"swepub:oai:gup.ub.gu.se/205823" > European perspectiv...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

European perspective on human polyomavirus infection, replication and disease in solid organ transplantation

Hirsch, H. H. (author)
Babel, N. (author)
Comoli, P. (author)
show more...
Friman, Vanda, 1952 (author)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
Ginevri, F. (author)
Jardine, A. (author)
Lautenschlager, I. (author)
Legendre, C. (author)
Midtvedt, K. (author)
Munoz, P. (author)
Randhawa, P. (author)
Rinaldo, C. H. (author)
Wieszek, A. (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2014
2014
English.
In: Clinical Microbiology and Infection. - : Elsevier BV. - 1198-743X. ; 20:suppl 7, s. 74-88
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Human polyomaviruses (HPyVs) are a growing challenge in immunocompromised patients in view of the increasing number of now 12 HPyV species and their diverse disease potential. Currently, histological evidence of disease is available for BKPyV causing nephropathy and haemorrhagic cystitis, JCPyV causing progressive multifocal leukoencephalopathy and occasionally nephropathy, MCPyV causing Merkel cell carcinoma and TSPyV causing trichodysplasia spinulosa, the last two being proliferative skin diseases. Here, the current role of HPyV in solid organ transplantation (SOT) was reviewed and recommendations regarding screening, monitoring and intervention were made. Pre-transplant screening of SOT donor or recipient for serostatus or active replication is currently not recommended for any HPyV. Post-transplant, however, regular clinical search for skin lesions, including those associated with MCPyV or TSPyV, is recommended in all SOT recipients. Also, regular screening for BKPyV replication (e.g. by plasma viral load) is recommended in kidney transplant recipients. For SOT patients with probable or proven HPyV disease, reducing immunosuppression should be considered to permit regaining of immune control. Antivirals would be desirable for treating proven HPyV disease, but are solely considered as adjunct local treatment of trichodysplasia spinulosa, whereas surgical resection and chemotherapy are key in Merkel cell carcinoma. Overall, the quality of the clinical evidence and the strength of most recommendations are presently limited, but are expected to improve in the coming years.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Merkel cell carcinoma
nephropathy
polyoma
progressive multifocal leukoencephalopathy
PyVAN
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
BK VIRUS NEPHROPATHY
MERKEL
CELL-CARCINOMA
LARGE T-ANTIGEN
RENAL-ALLOGRAFT RECIPIENTS
PEDIATRIC
KIDNEY RECIPIENTS
PROSPECTIVE SINGLE-CENTER
JC VIRUS
CLINICAL-IMPLICATIONS
LUNG TRANSPLANTATION
Infectious Diseases
Microbiology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view